Journey Medical Corporation - Common Stock (DERM)
7.2500
-1.2900 (-15.11%)
NASDAQ · Last Trade: Aug 13th, 6:25 PM EDT
Detailed Quote
Previous Close | 8.540 |
---|---|
Open | 7.410 |
Bid | 7.110 |
Ask | 7.700 |
Day's Range | 6.670 - 7.500 |
52 Week Range | 3.535 - 8.900 |
Volume | 484,841 |
Market Cap | 82.06M |
PE Ratio (TTM) | -18.59 |
EPS (TTM) | -0.4 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 157,991 |
Chart
About Journey Medical Corporation - Common Stock (DERM)
Journey Medical Corp is a healthcare company focused on the development and commercialization of innovative dermatological products. The company aims to address various skin conditions and enhance patient care through a diverse portfolio of prescription medications. By leveraging advanced research and clinical expertise, Journey Medical strives to improve treatment options for dermatological diseases while working collaboratively with healthcare providers to ensure the effective delivery of their products to patients. Read More
News & Press Releases
Via Benzinga · August 13, 2025
Via Benzinga · August 13, 2025
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via Chartmill · August 13, 2025
Via Benzinga · August 13, 2025

Company Announces Q3 Earnings and Conference Call Dates
Via ACCESSWIRE · October 17, 2024
Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading after it announced on Wednesday that it will be acquired by global private equity firm Advent in an all-cash transaction
Via Benzinga · August 13, 2025
Via Benzinga · August 12, 2025
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · August 12, 2025
Via Benzinga · June 11, 2025

Via Benzinga · November 29, 2024

Via Benzinga · November 4, 2024

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea.
Via Benzinga · November 4, 2024

DERM stock results show that Journey Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024

DALLAS, TX / ACCESSWIRE / July 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower portfolio companies.
Via ACCESSWIRE · July 17, 2024

Via Benzinga · June 10, 2024

DERM stock results show that Journey Medical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.
Via InvestorPlace · April 11, 2024

The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · March 28, 2024

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.
Via Benzinga · March 26, 2024

Via Benzinga · March 26, 2024